G Pezzotti, E Ohgitani, Y Fujita, H Imamura… - ACS Infectious …, 2023 - ACS Publications
The latest RNA genomic mutation of SARS-CoV-2 virus, termed the Omicron variant, has generated a stream of highly contagious and antibody-resistant strains, which in turn led to …
IV Astrakhantseva, AE Ershova, SA Chuvpilo… - International journal of …, 2023 - mdpi.com
The binding properties of synthetic and recombinant peptides derived from N-terminal part of ACE2, the main receptor for SARS-CoV-2, were evaluated. Additionally, the ability of these …
Abstract The COVID-19 Spike protein 24 LPP, 69 HV, 143 VYY, 156 FR, 212 L deletions, 215 EPE and 249 RWMD insertions were very well characterized. Changes in spike likely …
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel virus that belongs to the Coronoviridae family, emerged in December 2019, causing the COVID-19 pandemic …
Variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are emerging rapidly and offer surfaces that are optimized for recognition of host cell membranes while …
Background Since the onset of the COVID-19 pandemic, SARS-CoV-2 has evolved into independent new forms, variants of concern (VOCs). While epidemiological data showed …
T Hasse, E Mantei, R Shahoei, S Pawnikar… - PLOS Computational …, 2024 - journals.plos.org
The COVID-19 pandemic, driven by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spurred an urgent need for effective therapeutic interventions. The spike …
B Pedenko, G Sulbaran, D Guilligay, G Effantin… - Viruses, 2023 - mdpi.com
The SARS-CoV-2 pandemic has again shown that structural biology plays an important role in understanding biological mechanisms and exploiting structural data for therapeutic …
COVID-19 is a severe respiratory disease caused by SARS-CoV-2, a novel human coronavirus. Patients infected with SARS-CoV-2 exhibit heterogeneous symptoms that pose …